Emergence of 'femtomedicine' - new frontier of biomed sciences - reported at first global Congress on nano-medicine

Bombarding DNA nucleotides and mammalian meat with 'femto-neutrons' has opened up the path to 'femtomedicine,' an entirely new cancer diagnostics, it was reported yesterday at First Global Congress on NanoEngineering for Medicine and Biology in Houston, Texas, USA.

Femto-neutrons or 'femtons' are fast neutrons of femtometer wavelength, a million times shorter than the current nanotechnology diagnostic probes which operate on nanometer scale. In the first experiment of the kind, a collaboration of California Science & Engineering Corp (CALSEC) and College of Medicine, University of California, Irvine (UCI), claimed that is was able to detect oxygen differences as tiny as 1 atom of oxygen per molecule. Since hypoxic cancerous tumors contain 50% to 90% less oxygen than healthy tissue, if you find an oxygen difference between a tumor and the adjacent normal tissue - you have diagnosed cancer. The principle is named Differential Femto Oximetry and the patented diagnostic probe Oncosensor.

'We are ready and eager to test this interesting approach in vivo by making animals inhale carbogen, an oxygen-enriched harmless gas,' said co-author Orhan Nalcioglu, Professor and Director of the Center for Functional Onco Imaging of the UCI College of Medicine.